药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Roflumilast
Roflumilast may increase the immunosuppressive activities of Belinostat.
Methyprylon
Difluocortolone
The risk or severity of adverse effects can be increased when Belinostat is combined with Difluocortolone.
Methyprylon
Clobetasol
The risk or severity of adverse effects can be increased when Belinostat is combined with Clobetasol.
Methyprylon
Fluocortolone
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluocortolone.
Methyprylon
Hydrocortisone butyrate
The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone butyrate.
Methyprylon
Emapalumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Emapalumab.
Methyprylon
Hydrocortisone succinate
The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone succinate.
Methyprylon
Hydrocortisone acetate
The risk or severity of adverse effects can be increased when Belinostat is combined with Hydrocortisone acetate.
Methyprylon
Mometasone furoate
The risk or severity of adverse effects can be increased when Belinostat is combined with Mometasone furoate.
Methyprylon
Fluticasone
The risk or severity of adverse effects can be increased when Belinostat is combined with Fluticasone.
Methyprylon
Cloprednol
The risk or severity of adverse effects can be increased when Belinostat is combined with Cloprednol.
Methyprylon
Prednylidene
The risk or severity of adverse effects can be increased when Belinostat is combined with Prednylidene.
Methyprylon
Cortivazol
The risk or severity of adverse effects can be increased when Belinostat is combined with Cortivazol.
Methyprylon
Siponimod
The risk or severity of adverse effects can be increased when Belinostat is combined with Siponimod.
Methyprylon
Deflazacort
The risk or severity of adverse effects can be increased when Belinostat is combined with Deflazacort.
Methyprylon
Sarilumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Sarilumab.
Methyprylon
Dexamethasone isonicotinate
The risk or severity of adverse effects can be increased when Belinostat is combined with Dexamethasone isonicotinate.
Methyprylon
Meprednisone
The risk or severity of adverse effects can be increased when Belinostat is combined with Meprednisone.
Methyprylon
Olaparib
The risk or severity of adverse effects can be increased when Belinostat is combined with Olaparib.
Methyprylon
Palbociclib
The risk or severity of adverse effects can be increased when Belinostat is combined with Palbociclib.